The slip
PARKINSON RECEIPTno. 11595
27 Oct 2026, 05:23 UTCdopamine neurons, braak
predictionDEPP1 in dopamine neurons tracks Braak Lewy-body stage
registered192c1764b13eda17
discovery-0.14 p=0.716 n=9
replication-0.13 p=0.732 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.14, p 0.716)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTfedcfbae43825eb8272f102c…
follows ec9550764eb2…
Covered by the on-chain checkpoint of receipt 11605 (2026-10-27 05:37 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11595: DEPP1 in dopamine neurons, braak
- power
- full sample -0.11 (p 0.664, n 18), 95% CI -0.55 to +0.38. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.06 (p 0.827, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.16 (p 0.515, n 18). could be the mix.
- skeptic
- leave-one-out range -0.28 to +0.01, sign flips 1; without severely affected donors -0.11 (p 0.664, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.61 (p 0.0077, n 18) vs -0.11 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DEPP1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DEPP1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.48 p 0.091 (needs p < 1.9e-4)